TY  - GEN
AU  - Millward,M
AU  - Underhill,C
AU  - Lobb,S
AU  - McBurnie,J
AU  - Meech,S J
AU  - Gomez-Navarro,J
AU  - Marshall,M A
AU  - Huang,B
AU  - Mather,C B
TI  - Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
SN  - 1532-1827
PY  - 2013///0726
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasms
KW  - Oligodeoxyribonucleotides
KW  - Skin Neoplasms
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2013.227
ER  -